Preventing Overdoses with Test Strips Act

HR 5801, the Preventing Overdoses with Test Strips Act, amends the 21st Century Cures Act and the Public Health Service Act to allow federal grant funds (administered by SAMHSA) to cover the cost of fentanyl and xylazine test strips. It directly affects substance abuse prevention programs receiving SAMHSA grants by enabling them to purchase devices that detect dangerous drugs like fentanyl and xylazine in drug samples before use. The bill defines "adulterant substance detection devices" as tools, including test strips, that identify harmful substances in drugs. This policy change authorizes existing grant programs to include these detection tools without requiring new funding.